Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bendtsen

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Diagnostics (Basel, Switzerland)|February 10, 2024
Pericranial Muscle Stiffness, Pain Thresholds, and Tenderness during a Treatment Cycle of OnabotulinumtoxinA for Chronic Migraine PreventionSebastian Worsaae Dalby, Jeppe Hvedstrup, Louise Ninett Carlsen, et al.
The Journal of Headache and Pain|September 28, 2018
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache FederationLars Bendtsen, Simona Sacco, Messoud Ashina, et al.
The Journal of Headache and Pain|January 18, 2019
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine preventionSimona Sacco, Lars Bendtsen, Messoud Ashina, et al.
Headache|June 19, 2015
Familial Hemiplegic Migraine and Recurrent Episodes of Psychosis: A Case ReportSonja LaBianca, Rigmor Jensen, Arn M J M van den Maagdenberg, et al.
The Journal of Headache and Pain|April 1, 2011
Facial pain and multiple cranial palsies in a patient with skin cancerJanina Viken, Lars Bendtsen, Klaus Hansen, et al.
Cephalalgia : an International Journal of Headache|February 9, 2019
Complete withdrawal is the most effective approach to reduce disability in patients with medication-overuse headache: A randomized controlled open-label trialMia Nielsen, Louise Ninett Carlsen, Signe Bruun Munksgaard, et al.
European Journal of Pain (London, England)|May 3, 2005
No release of interstitial glutamate in experimental human model of muscle painMessoud Ashina, Marianne Jorgensen, Bente Stallknecht, et al.
Cephalalgia : an International Journal of Headache|October 30, 2016
Persistent idiopathic facial pain - a prospective systematic study of clinical characteristics and neuroanatomical findings at 3.0 Tesla MRIStine Maarbjerg, Frauke Wolfram, Tone Bruvik Heinskou, et al.
European Journal of Pain (London, England)|February 23, 2019
Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trialIda Maria Storm Engelstoft, Louise Ninett Carlsen, Signe Bruun Munksgaard, et al.
Headache|July 29, 2021
Treatment of medication overuse headache: Effect and predictors after 1 year-A randomized controlled trialLouise N Carlsen, Carolien Rouw, Maria L Westergaard, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Diagnostics (Basel, Switzerland)|February 10, 2024
Pericranial Muscle Stiffness, Pain Thresholds, and Tenderness during a Treatment Cycle of OnabotulinumtoxinA for Chronic Migraine PreventionSebastian Worsaae Dalby, Jeppe Hvedstrup, Louise Ninett Carlsen, et al.
The Journal of Headache and Pain|September 28, 2018
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache FederationLars Bendtsen, Simona Sacco, Messoud Ashina, et al.
The Journal of Headache and Pain|January 18, 2019
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine preventionSimona Sacco, Lars Bendtsen, Messoud Ashina, et al.
Headache|June 19, 2015
Familial Hemiplegic Migraine and Recurrent Episodes of Psychosis: A Case ReportSonja LaBianca, Rigmor Jensen, Arn M J M van den Maagdenberg, et al.
The Journal of Headache and Pain|April 1, 2011
Facial pain and multiple cranial palsies in a patient with skin cancerJanina Viken, Lars Bendtsen, Klaus Hansen, et al.
Cephalalgia : an International Journal of Headache|February 9, 2019
Complete withdrawal is the most effective approach to reduce disability in patients with medication-overuse headache: A randomized controlled open-label trialMia Nielsen, Louise Ninett Carlsen, Signe Bruun Munksgaard, et al.
European Journal of Pain (London, England)|May 3, 2005
No release of interstitial glutamate in experimental human model of muscle painMessoud Ashina, Marianne Jorgensen, Bente Stallknecht, et al.
Cephalalgia : an International Journal of Headache|October 30, 2016
Persistent idiopathic facial pain - a prospective systematic study of clinical characteristics and neuroanatomical findings at 3.0 Tesla MRIStine Maarbjerg, Frauke Wolfram, Tone Bruvik Heinskou, et al.
European Journal of Pain (London, England)|February 23, 2019
Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trialIda Maria Storm Engelstoft, Louise Ninett Carlsen, Signe Bruun Munksgaard, et al.
Headache|July 29, 2021
Treatment of medication overuse headache: Effect and predictors after 1 year-A randomized controlled trialLouise N Carlsen, Carolien Rouw, Maria L Westergaard, et al.
Pageof 10